Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-02 11:07:45 - browse：68694

Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store. — The FDA is ramping up its efforts to force vape shops and other retailers to stop selling Elf Bar and Esco Bar products. PATRICK T. FALLON/AFP via Getty Images

WASHINGTON — The Food and Drug Administration is ramping up its efforts to force vape shops and other retailers to stop selling unauthorized disposable vape brands that are increasingly popular with young people.

The FDA recently issued 189 formal warning letters to shops selling two brands of vape products, Elf Bar and Esco Bars, the agency announced in a press release Thursday. The FDA has not authorized either brand, both of which are ubiquitous in gas stations and smoke shops around the country. They are therefore illegal to sell.

“This latest blitz should be a wake-up call for retailers of Elf Bar and Esco Bars products nationwide,” said Brian King, the head of the FDA’s tobacco center in a statement announcing the blitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Report captures long Covid’s disabling effects and policy challenges

focus

WSS

Why Eli Lilly’s earnings didn’t quite live up to the hype

Study: Why relieving medical debt did not improve financial outcomes

Resistance to opioid

Having children helps parents live longer, especially after age 80

Statins may not be needed by millions of people, study suggests

Curing rare childhood diseases will falter unless Congress steps up

hotspot

Wikipedia

knowledge

Heart attack and stroke risk calculators need revising

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Walensky prepares to leave CDC — and Congress — behind

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Medical records are filled with copy

Artificial intelligence use in health care faces greater scrutiny in 2024

Virginia high school admissions case could be legal follow

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Moonlake's readout produced a cash windfall. Risks remain

Lilly's Alzheimer's drug donanemab backed by FDA advisers

leisure time

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Health care court cases: Humana, Sutter, Novant

Why don't Americans have at

How faith leaders like me can help address America's obesity epidemic

Cigna wins case to block Amy Bricker's move to CVS

Report captures long Covid’s disabling effects and policy challenges

explore

focus

focus

focus